Key Insights

Highlights

Treatment Research

2 treatments under study, led by 177luludotastr17126

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Early Phase 1 (1)

Trial Status

Recruiting1

Clinical Trials (1)

Showing 1 of 1 trials
NCT07608848Early Phase 1Recruiting

First-in-human Diagnostic Imaging Profile of the Theranostic Pair [68Ga]Ga-DOTA-STR-17126 and Low Dose [177Lu] Lu-DOTA-STR-17126 in Patients With Advanced or Metastatic Cancer

Showing all 1 trials

Research Network

Common Treatments

  • 177luludotastr171261
  • 68gagadotastr171261

Active Sponsors

  • Integrated Haematology and Oncology Network1

Top Investigators

  • Nat Lenzo, MD1

    Integrated Hematology Oncology Network (Icon Group)

Related Conditions

  • Grprtargeted Molecular Imaging1
  • Theranostic1
  • Active Cancer1
  • Metastatic Prostate Cancer1
  • Cancer1

Activity Timeline